§ 13F · FUND PROFILE
BAKER BROS. ADVISORS LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $13838.8T (13F)Positions · 91Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$142.3T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | INCY | Incyte Corporation | 30.74M | $3036.6T | 17.8% | ±0% |
| 2 | ONC | BeOne Medicines Ltd. | 8.80M | $2673.2T | 15.7% | ±0% |
| 3 | MDGL | Madrigal Pharmaceuticals, Inc. | 2.14M | $1247.2T | 7.3% | ±0% |
| 4 | INSM | Insmed Incorporated | 6.59M | $1147.4T | 6.7% | −2% |
| 5 | ACAD | ACADIA Pharmaceuticals Inc. | 42.90M | $1145.8T | 6.7% | ±0% |
| 6 | CELC | Celcuity Inc. | 7.92M | $789.5T | 4.6% | ±0% |
| 7 | RVMD | Revolution Medicines, Inc. | 9.46M | $753.1T | 4.4% | ±0% |
| 8 | KYMR | Kymera Therapeutics, Inc. | 8.66M | $673.6T | 3.9% | +30% |
| 9 | SMMT | Summit Therapeutics Inc. | 36.39M | $636.5T | 3.7% | +8% |
| 10 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.60M | $599.9T | 3.5% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE BAKER SIGNAL
AC read
BAKER BROS. ADVISORS LP is a Other fund managing $13838782.0 trillion in assets. The fund runs a portfolio of 91 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed